PMA device
Total Artificial Heart
Syncardia Systems, LLC · Artificial Heart (LOZ, Class III) · First FDA decision Jan 4, 2011, newest Nov 19, 2025Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
2,049
Naming "Artificial"
MAUDE reports
3,036
Brand "Artificial", since 2015
PubMed studies
368,482
Mentioning "Artificial"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Total Artificial Heart
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Total Artificial HeartPMA supplement
P030011-S093 · Decided Nov 19, 2025 · 517 days after receipt · Normal 180 Day Track
Device type: Artificial heart (LOZ) · Cardiology
- Total Artificial HeartPMA supplement
P030011-S092 · Decided Nov 25, 2024 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Artificial heart (LOZ) · Cardiology
- Total Artificial HeartPMA supplement
P030011-S081 · Decided Jun 25, 2025 · 1,050 days after receipt · Normal 180 Day Track No User Fee
Device type: Artificial heart (LOZ) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Artificial Hearts and related devices, including Ventricular Assist Devices for Bridge-to-Transplant and Destination TherapyNational analysisReview closedCAG-00453NUpdated Nov 19, 2026
- Artificial HeartsNational analysisReview closedCAG-00322NUpdated Sep 16, 2026
- Artificial Hearts and Related Devices - RETIREDNational determinationOn the books20.9Updated Jun 5, 2024
- Lumbar Artificial Disc Replacement (LADR)National determinationOn the books150.10Updated Nov 4, 2026
- Lumbar Artificial Disc Replacement (LADR)National analysisReview closedCAG-00292RUpdated Sep 18, 2026
- Lumbar Artificial Disc ReplacementNational analysisReview closedCAG-00292NUpdated Sep 18, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39851Palmetto GBAUpdated Oct 7, 2026
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)Local determinationIn effectL39863Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Artificial", any status and sponsor, newest update first.
- CPAP vs High-Flow Nasal Cannula for Treating Sleep Apnea in ChildrenPivotal-lookingRecruiting
The Hospital for Sick ChildrenAcademic, hospital or other
NCT07600333 · 258 participants (planned) · Start May 27, 2026 · Primary completion Nov 2031
Device: High Flow Nasal Cannula; Continuous Positive Airway Pressure · For: Obstructive Sleep Apnea (OSA)
Sites: Toronto, Canada
- High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart SurgeryPivotal-lookingCompleted
Universitas IndonesiaAcademic, hospital or other
NCT07059689 · 120 participants · Start Jun 5, 2025 · Primary completion Sep 15, 2026
Device: High Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV) · For: Heart Defects, Congenital; Intensive Care Units, Pediatric; Respiration, Artificial and 1 more
Sites: Jakarta, Indonesia
- Physiological Associations and Prognostic Discrimination of an EIT-Derived Flow Index During Noninvasive VentilationNot yet recruiting
Ruijin HospitalAcademic, hospital or other
NCT07948967 · 220 participants (planned) · Start Dec 1, 2026 · Primary completion Sep 30, 2028
Device: Electrical Impedance Tomography (EIT) Monitoring · For: Acute Hypoxemic Respiratory Failure; Noninvasive Ventilation
Sites: Shanghai, China
2,046 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Artificial", and for the whole product code for context.
This brand
3,036 reports: 133 malfunction, 2,721 injury, 177 death
Whole product code LOZ
3,209 reports: 2,545 malfunction, 279 injury, 384 death
Newest reports for this brand
2124215-2026-57526 · Received Oct 29, 2026 · Event dated Oct 12, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Urinary Incontinence
2124215-2026-57528 · Received Oct 29, 2026 · Event dated Oct 8, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Unspecified Infection; Urinary Incontinence
2124215-2026-57537 · Received Oct 29, 2026 · Event dated Oct 13, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Fluid/Blood Leak; Mechanical Problem
Patient problem as coded: Urinary Incontinence
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0126-2024 · Started Aug 1, 2023 · Posted by FDA Oct 20, 2023
Reason given: Artificial hearts contain a epoxy resin that has not been reviewed by the FDA for safety and efficacy.
Cause as FDA categorized it: Other · Device type: Artificial Heart (LOZ)
- SynCardia Total Artificial Heart System (70CC): 500101-001 SynCardia Total Artificial Heart System (50CC): 570500-000Open, Classified
Z-1022-2023 · Started Nov 2, 2022 · Posted by FDA Jan 27, 2023
Reason given: Due to tears reported tears in the cannula due to wear and tear stress.
Cause as FDA categorized it: Device Design · Device type: Artificial Heart (LOZ)
Z-0659-2017 · Started Oct 21, 2016
Reason given: The Main Printed Circuit Board Assembly (PCBA) of the affected Freedom Drivers may fail and cause the Freedom Driver to stop functioning without visual or audible alarms, resulting in the loss of life-sustaining function.
Cause as FDA categorized it: Process control · Device type: Artificial Heart (LOZ)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Artificial"[tiab]. The summary above synthesizes these.
- Artificial Intelligence in Anesthesiology: Current Techniques, Clinical Applications, and Limitations.
Hashimoto DA, Witkowski E, Gao L, et al. · Anesthesiology · 2020Review
- Ethics and artificial intelligence.
Inglada Galiana L, Corral Gudino L, Miramontes González P · Rev Clin Esp (Barc) · 2024Review
- Artificial Tears: A Systematic Review.
Semp DA, Beeson D, Sheppard AL, et al. · Clin Optom (Auckl) · 2023Review
- Artificial blood.
Sarkar S · Indian J Crit Care Med · 2008
- Artificial intelligence and deskilling in medicine.
Monteith S, Glenn T, Geddes JR, et al. · Br J Psychiatry · 2026Review
- Artificial Neuron Devices.
He K, Wang C, He Y, et al. · Chem Rev · 2023Review, Research Support, Non-U.S. Gov't
- Artificial intelligence to advance acute and intensive care medicine.
Biesheuvel LA, Dongelmans DA, Elbers PWG · Curr Opin Crit Care · 2024Review, Research Support, Non-U.S. Gov't
- Artificial intelligence impacts in education and pediatric mental health.
Liberatore G, Kim A, Brenner J, et al. · Curr Opin Pediatr · 2025Review
- Is the Use of Artificial Sweeteners Beneficial for Patients with Diabetes Mellitus? The Advantages and Disadvantages of Artificial Sweeteners.
Iizuka K · Nutrients · 2022Review
- Artificial Intelligence in Pathology.
Chang HY, Jung CK, Woo JI, et al. · J Pathol Transl Med · 2019
- Artificial Photosynthesis: Beyond Mimicking Nature.
Dau H, Fujita E, Sun L · ChemSusChem · 2017Editorial, Introductory Journal Article
- Virtues for AI.
Ohlhorst J · AI Soc · 2025
Other devices of this type
Also filed under product code LOZ.
- SynCardia temporary Total Artificial Heart (TAH-t) SystemSyncardia Systems, LLC · PMA 2023
- Syncardia Companion 2 Driver SystemSyncardia Systems, LLC · PMA 2012
- Cardiowest Temporary Total Artifical Heart (Tah-T) SystemSyncardia Systems, LLC · PMA 2008
- Syncardia Temporary Cardiowest Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2005
- Syncardia Temporary Cardio West Total Artificial Heart (Tah-T)Syncardia Systems, LLC · PMA 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.